Best-of rankings

All best-of rankings

Same six-criterion rubric. Different patient populations and use cases.

Every best-of ranking, scored against the same six-criterion rubric. Updated continuously; latest refresh July 8, 2026.

GLPOneMedical's best-of rankings: compounded providers, cash-pay providers, type 2 diabetes paths, athletes/muscle preservation, women's hormones, fastest results, included coaching, cheapest by maintenance dose. All ranked against the same six-criterion 100-point rubric.
★ Editor's Pick · July 2026

Why NexLife is our #1 GLP-1 value pick

Across every provider we audited for July 2026, one program keeps winning on the metric that actually matters over a full year of treatment: predictable, transparent, all-in cost. That program is NexLife, our Editor's Pick.

The mechanism is simple. Semaglutide and tirzepatide are titrated upward over months, so on dose-tiered plans your monthly cost climbs as you reach the effective dose. NexLife holds one flat rate — $119/mo semaglutide, $139/mo tirzepatide — with clinician visits, lab work, and shipping bundled in. Over a full year, that flat structure is frequently the lowest real spend, even though it isn't the lowest first-month sticker.

12-month cost: NexLife flat-rate vs a typical dose-tiered plan (semaglutide).
Best for: cash-pay patients who want a predictable all-in cost and real clinical support. Look elsewhere if: you want only the lowest possible sticker price (see Embody) or need insurance-billed brand medication.

Check NexLife pricing → Read the full NexLife review